[PDF] Top 20 Análisis sintomático de empresas en proceso de quiebra
Has 10000 "Análisis sintomático de empresas en proceso de quiebra" found on our website. Below are the top 20 most common "Análisis sintomático de empresas en proceso de quiebra".
<p>The protective effect and mechanism of the FXR agonist obeticholic acid via targeting gut microbiota in non-alcoholic fatty liver disease</p>
... To assess the level of gene expression of tight junction protein- 1 (ZO-1), occludin, TNF- α , interleukin-1 β (IL-1 β ), IL-10, fi broblast growth factor 15 (Fgf15), cholesterol 7 α - hydroxylase (CYP7A1), sterol 12 α ... See full document
12
<p>A Review Of Current And Upcoming Treatment Modalities In Non-Alcoholic Fatty Liver Disease And Non-Alcoholic Steatohepatitis</p>
... NASH. Obeticholic acid (OCA) is a FXR agonist and bile acid analogue with a 100-fold greater potency on ...Ligand Obeticholic Acid in Nash treatment (FLINT) trial was a ... See full document
10
Original Article Anti-inflammation effect via TLR4-mediated MyD88-dependent and -independent signalling pathways in non-alcoholic fatty liver disease rats: Chinese herb formula
... the gut microbiota, which is believed to be intimately associated with the severity of NAFLD ...the gut microbiota would strength- en intestinal permeability, resulting in the accu- mulation ... See full document
10
The FLS (Fatty liver Shionogi) mouse reveals local expressions of lipocalin-2, CXCL1 and CXCL9 in the liver with non-alcoholic steatohepatitis
... FLS and DS mice (9 each), aged 12 weeks, were obtained from Aburabi Laboratories, Shionogi Research Laboratories (Shionogi and Co., Ltd, Shiga, Japan).The FLS mice were derived from the C line of an outbred ddN colony ... See full document
9
Using non invasive biomarkers to identify hepatic fibrosis in people with type 2 diabetes mellitus: the Edinburgh type 2 diabetes study
... NAFLD non-alcoholic fatty liver disease; NAFL non-alcoholic fatty liver; NASH non- alcoholic steatohepatitis; CLD chronic liver ... See full document
22
Non-alcoholic fatty liver disease: introspection
... the liver by facilitating oxidative damage of the proteins ...heart disease when consumed in place of SFAs in both ...α-linolenic acid improved peripheral insulin sensitivity and lowered cholesterol ... See full document
9
Association between Serum Uric Acid and Non-Alcoholic Fatty Liver Disease and Its Correlation with Liver Fibrosis as Assessed by Fibroscan
... Since patients with NASH have coexisting hyperlipidemia, the use of lipid-lowering agents has been studied as a potential treatment to address both the conditions. The most commonly used agents for hyperlipidemia are ... See full document
154
Effect of coexisting diabetes mellitus and chronic kidney disease on mortality of cirrhotic patients with esophageal variceal bleeding
... In a cohort study with patients with chronic hepatitis C (CHC), patients with new-onset diabetes subsequently were found to have an increased risk of developing cir- rhosis, or decompensation in those with established ... See full document
32
Systems Genetics of Hepatic Metabolome Reveals Octopamine as a Target for Non-Alcoholic Fatty Liver Disease Treatment.
... In conclusion, our indings contribute to improved fundamental knowledge of NAFLD etiopathogenesis in the context of gene x diet interaction. Even though the size of the cross and the duration of fat feeding may have ... See full document
108
The combined effect of non alcoholic fatty liver disease and metabolic syndrome on colorectal carcinoma mortality: a retrospective in Chinese females
... exacerbating effect on the other ...synergetic effect of NAFLD and MetS has been proved in numerous diseases ...influence disease pro- gression ... See full document
155
Analysis of factors influencing glucose tolerance in Japanese patients with non-alcoholic fatty liver disease
... and non-progressors to diabetes differ essentially in that progressors can- not compensate by increased insulin secretion for the increased demand due to increased insulin resistance; non-progressors are ... See full document
92
Obeticholic acid for the treatment of primary biliary cholangitis in adult patients: clinical utility and patient selection
... autoimmune liver disease characterized by the hallmark autoantibodies to mitochon- drial antigens and immune-mediated destruction of small bile duct epithelial cells leading to cholestasis and ...bile ... See full document
9
Flaxseed oil ameliorates alcoholic liver disease via anti-inflammation and modulating gut microbiota in mice
... Gut microbiota play a crucial role in progression and pathogenesis of ...that gut microbiota is closely associated with liver in ALD as the gut-liver axis [6, ...of ... See full document
37
Daily Consumption of Angelica Keiskei Juice Attenuated Hyperlipidaemia and Hepatic Steatosis Caused by Western Diet in C57BL/6J Mice
... the liver through portal vein ...stimulate liver-resident macrophages called Kupffer cells, thereby leading to oxidative stress and inflammation related hepatic damage ...additive effect of high-fat ... See full document
25
<p>Plant-derived oleanolic acid ameliorates markers associated with non-alcoholic fatty liver disease in a diet-induced pre-diabetes rat model</p>
... have protective effects against cardiovascular dis- eases such as atherogenesis, coronary artery disease, as well as peripheral arterial ...of liver damage include aminotransferase enzymes such as ... See full document
16
Gut Microbiota Mediates the Protective Effects of Dietary Capsaicin against Chronic Low Grade Inflammation and Associated Obesity Induced by High Fat Diet
... altered gut microbiota (7) and microbiota-derived metabolites (23) have been shown as major causes for the development of metabolic ...on gut microbiota, we analyzed the composition, ... See full document
96
Measuring the human gut microbiome: new tools and non alcoholic fatty liver disease
... to gut microbiome data from a nonalcoholic fatty liver disease cohort to examine the potential role of the microbiota in this ... See full document
118
A Study on Serum Levels of C-reactive Protein and Its relation to Clinical and Laboratory Profile of Asymptomatic Cases Diagnosed with Fatty Liver Disease by Radiological Screening
... Fatty liver can be defined by the presence of at least two of three abnormal findings on abdominal ultrasonography: diffusely increased echogenicity (‘bright') liver with liver echogenicity ... See full document
24
Non-alcoholic fatty liver disease
... a liver biopsy to identify the pres- ence and location of its features such as inflammation, hepatocyte ballooning, Mallory-Denk bodies, and early fibrosis ...biopsy, non-invasive means of detecting NASH ... See full document
127
Gut microbiota manipulation with prebiotics in patients with non-alcoholic fatty liver disease: a randomized controlled trial protocol
... the gut microbiota to prevent or treat condi- tions such as obesity and inflammatory bowel ...the gut microbiota, targeted dietary interventions such as prebiotics or probiotics are easy to ... See full document
67
Related subjects